Biểu đồ giá cổ phiếu NRSN
NRSN Thu nhập
Neurosense Therapeutics Ltd
$0.8
7.78%
$0.05
Khi đóng cửa: Apr 28, 16:00:00 GMT-4
$0.78
-3.57%
$-0.02
Phiên trước giờ: Apr 29, 06:59:45 GMT-4
Quay lại
Neurosense Therapeutics Ltd (NRSN) Thu nhập
Thống kê chính
Giá đóng cửa trước
$0.7505
Giá mở cửa
$0.8
Phạm vi ngày
$0.75 - $0.84
Phạm vi 52 tuần
$0.63 - $2.6
Khối lượng
381.5K
Khối lượng trung bình
201.4K
Tỷ suất cổ tức
--
EPS (TTM)
-0.62
Vốn hóa thị trường
$27.5M
NRSN là gì?
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
